No, molly (MDMA) does not put holes in your brain. This is one of the most persistent drug myths out there, and it comes from a misunderstanding of how brain scans work. That said, MDMA is not harmless. It can damage the wiring between nerve cells in ways that affect memory and mood, especially with heavy or frequent use. The real story is more nuanced than a hole in your head, but it’s still worth understanding.
Where the “Holes” Myth Came From
The claim traces back to SPECT scans that were shown in anti-drug campaigns and media segments during the 1990s and early 2000s. SPECT imaging measures blood flow in the brain, and areas with lower blood flow show up as dark spots or gaps on the scan. When these images were presented to the public, the dark areas looked like literal holes in brain tissue. They weren’t. A SPECT scan doesn’t show brain structure the way an MRI does. It shows activity. A dark spot means reduced blood flow in that region, not missing tissue.
Modern structural brain imaging, including MRI and a technique called diffusion tensor imaging (DTI), has been used to look at the brains of MDMA users. These scans show subtle changes in the quality of white matter connections, particularly in the corpus callosum, the thick bundle of fibers connecting the two halves of the brain. But they do not show holes, gaps, or missing brain matter. The physical architecture of the brain remains intact.
What MDMA Actually Does to Nerve Cells
The real concern with MDMA isn’t holes. It’s damage to the long, thin extensions of serotonin-producing nerve cells, called axons and axon terminals. Serotonin is the brain’s key chemical messenger for mood, sleep, appetite, and emotional regulation. MDMA floods the brain with serotonin and dopamine at the same time. After the serotonin is dumped out, the nerve cell is left depleted. Excess dopamine then gets pulled into the emptied serotonin terminal, where it gets broken down in a way that produces free radicals, which are chemically reactive molecules that damage the cell from the inside. This chain of events can degrade the serotonin nerve endings themselves.
This isn’t the same as killing brain cells outright. The cell bodies survive. But the connections they use to communicate get pruned back, which reduces the brain’s serotonin signaling capacity. Think of it less like punching a hole through a wall and more like fraying the wires inside it.
Heat Makes the Damage Worse
One of the most important factors in MDMA-related brain damage is body temperature. Animal research has shown that when MDMA is taken in cool environments, neurotoxic effects on serotonin systems can be minimal or even absent. But when ambient temperature rises, the damage increases dramatically and correlates directly with how high core body temperature gets.
In rat studies, MDMA given at room temperatures between 20 and 24°C (68–75°F) produced no measurable serotonin damage in the frontal cortex, hippocampus, or striatum. At ambient temperatures of 26–30°C (79–86°F), neurotoxicity appeared and scaled with body temperature. This matters because molly is most commonly taken at concerts, clubs, and festivals, all environments with high temperatures, physical exertion, and dehydration. The drug itself raises body temperature, and a hot environment amplifies that effect. The combination is what tips the balance toward real neurological harm.
Importantly, high body temperature alone doesn’t cause the damage. Blocking MDMA from entering serotonin neurons (as the antidepressant fluoxetine does) prevents neurotoxicity even when body temperature stays elevated. It’s the interaction between the drug being inside the nerve cell and the heat accelerating destructive chemical reactions that does the harm.
Effects on Memory and Thinking
The most consistent finding in research on regular MDMA users is impaired learning and memory. A 2025 meta-analysis pooling results across multiple studies found that both current and former MDMA users performed significantly worse on memory tasks compared to people who had never used the drug. The effect sizes were large: current users showed a deficit roughly one standard deviation below controls, and former users who had stopped taking MDMA performed similarly poorly, with no meaningful difference between the two groups.
Studies on decision-making tell a similar story. MDMA users in one DTI imaging study scored higher on impulsiveness measures and made more disadvantageous choices on a gambling task designed to test real-world decision-making. These behavioral differences correlated with the white matter changes visible on their brain scans.
Dose matters. Research using EEG (which measures electrical brain activity) found that people who had taken fewer than 100 ecstasy tablets over their lifetime showed essentially normal brain wave patterns. Those who had taken 100 or more showed measurable shifts, including increased slow-wave activity and decreased dominant brain rhythms, patterns associated with reduced cognitive processing efficiency. The changes were dose-dependent, growing more pronounced in the heaviest users.
Can the Brain Recover?
There is encouraging evidence that the serotonin system can bounce back after people stop using MDMA. A study using PET imaging to measure serotonin transporter density found that former MDMA users who had been abstinent for at least one year showed no differences compared to people who had never used the drug or to matched controls who used other drugs but not MDMA. This suggests that the serotonin nerve endings can regrow over time once the repeated insult stops.
However, the memory findings are less reassuring. The meta-analysis that found large memory deficits in current users found nearly identical deficits in abstinent former users. This could mean that some cognitive effects persist even after the serotonin system has structurally recovered, or it could reflect limitations in how the studies were designed. Either way, it suggests that memory problems from heavy use may not fully resolve on their own.
Street Molly Carries Extra Risks
One complication in understanding molly’s effects is that what’s sold as molly often isn’t pure MDMA. Street supplies are frequently adulterated, contaminated, or entirely replaced with other substances. Common substitutes and adulterants include methamphetamine, caffeine, ketamine, cocaine, dextromethorphan, synthetic cathinones (bath salts), and in some cases fentanyl. Some ecstasy tablets contain no MDMA at all.
This means that some of the worst outcomes people associate with molly, including severe overheating, seizures, or overdose deaths, may involve substances the user didn’t know they were taking. It also makes it harder to separate MDMA’s actual risks from the risks of unknown contaminants. Clinical trials using pharmaceutical-grade MDMA for PTSD therapy have reported no serious adverse events across multiple studies, with no evidence of neurotoxic harm, abuse, or dependence at controlled doses in supervised settings. That gap between clinical and street use is significant.
The Bottom Line on Brain Damage
MDMA does not create physical holes in brain tissue. That image was a misreading of blood flow scans. What it can do, particularly with repeated use in hot environments, is degrade the serotonin wiring that supports mood, memory, and decision-making. These effects are dose-dependent, temperature-dependent, and at least partially reversible with sustained abstinence. The serotonin system appears capable of structural recovery over a year or more, though some cognitive effects, especially around memory, may linger. Street molly adds a layer of unpredictability because of widespread contamination with other drugs, some of which carry their own serious risks.